Role of 18F-FDG PET/CT, 123I-MIBG SPECT, and CT in restaging patients affected by malignant Pheochromocytoma

被引：8
作者：
Cantalamessa A. [1 ]
Caobelli F. [2 ]
Paghera B. [3 ]
Caobelli A. [1 ]
Vavassori F. [1 ]
机构：
[1] Department of Internal Medicine, Habilita Istituto Clinico, Bergamo
[2] Department of Nuclear Medicine, University of Brescia, 25133 Brescia, P.le Spedali Civili
[3] Department of Nuclear Medicine, Brescia, Spedali Civili
来源：
Nuclear Medicine and Molecular Imaging | 2011年 / 45卷 / 2期
关键词：
MIBG; Paraganglioma; PET; Pheochromocytoma; SPECT;
D O I：
10.1007/s13139-011-0083-y
中图分类号：
学科分类号：
摘要：
Purpose (PH) is a rare catecholaminesecreting tumor that arises from chromaffin tissue within the adrenal medulla and extra-adrenal sites; commonly it is sporadic, and malignant PH accounts for about 10% of all cases. Several imaging modalities have been used for the diagnosis and staging of this tumor: functional imaging using radio-labelled metaiodobenzylguanidine and, more recently, 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET/CT), which offers substantial sensitivity and specificity to correctly detect metastatic PH and helps to identify patients suitable for treatment with radiopharmaceuticals. The aim of our study was to compare CT, 18F-FDG PET/CT, and 123I-metaiodobenzylguanidine single photon emission tomography (123I-MIBG SPECT) as feasible methods to restage patients diagnosed histologically with PH. Methods We retrospectively evaluated 38 patients (27 females and 11 males; mean age: 44±15 years) with malignant PH documented histologically after surgical intervention. These patients underwent CT, 18F-FDG PET/ CT, and 123I-MIBG SPECT. Results 18F-FDG PET/CT showed positive results for neoplastic tissue in 33/38 patients (86.8%) and negative in 5/38 (13.2%), in concordance with CT alone. 123I-MIBG SPECT was positive in 30/38 patients (78,9%) and negative in 8/38 (21.1%). No differences in lesion numbers were found between 18F-FDG PET/CT and CT, whereas a difference could be demonstrated between 18F-FDG PET/ CT and 123I-MIBG SPECT. Conclusion 18F-FDG PET/CT could more accurately restage patients with PH than CT and 123I-MIBG SPECT, also in the absence of a staging study. © Korean Society of Nuclear Medicine 2011.
引用
收藏
页码：125 / 131
页数：6
相关论文
共 20 条
  • [1] Frankel F., Ein Fall von doppelseitigem, völlig latent verlaufenen Nebennierentumor und gleichzeitiger Nephritis mit Veränderungen am Circulationsapparat und Retinitis, Arch Pathol Anat Physiol Klin Med., 103, pp. 244-263, (1886)
  • [2] Grossman A.B., Kaltsas G.A., Adrenal medulla and pathology, Comprehensive clinical endocrinology, pp. 223-237, (2002)
  • [3] Bravo E.L., Tagle R., Pheochromocytoma: State-of-the-art and future prospects, Endocr Rev., 24, pp. 539-553, (2003)
  • [4] Brouwers F.M., Elkahloun A.G., Munson P.J., Et al., Gene expression profiling of benign and malignant pheochromocytoma, Ann NY Acad Sci., 1073, pp. 541-556, (2006)
  • [5] Loh K.C., Fitzgerald P.A., Matthay K.K., Et al., The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (<sup>131</sup>I-MIBG): A comprehensive review of 116 reported patients, J Endocrinol Invest., 20, pp. 648-658, (1997)
  • [6] Bravo E.L., Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma, Endocr Rev., 15, pp. 356-368, (1994)
  • [7] Shulkin B.L., Thomopson R.W., Shapiro B., Et al., Pheochromocytomas: I with 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose PET, Radiology., 212, pp. 35-41, (1999)
  • [8] Taieb D., Sebag F., Barlier A., Et al., <sup>18</sup>F-FDG avidity of pheochromocytomas and paragangliomas: A new molecular imaging signature?, J Nucl Med., 50, pp. 711-717, (2009)
  • [9] Timmers H.J., Chen C.C., Carrasquillo J.A., Et al., Comparison of <sup>18</sup>Ffluoro-L-DOPA, <sup>18</sup>F-fluoro-deoxyglucose and <sup>18</sup>F-fluorodopamine PET and <sup>123</sup>I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma, J Clin Endocrinol Metab., 94, pp. 4757-4767, (2009)
  • [10] Takano A., Oriuchi N., Tsushima Y., Et al., Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: Comparison with <sup>18</sup>F-FDG positron emission tomography and 123I-MIBG scintigraphy, Ann Nucl Med., 22, pp. 395-401, (2008)
12